Kenvue (NYSE: KVUE) is a publicly listed company headquartered in Summit, New Jersey, United States that owns 13 consumer brands across 2 categories, and has 1 recorded transaction.[1]
Kenvue is the consumer health business separated from Johnson & Johnson, listed in May 2023 and fully split off that August. It holds the self-care, skin health and essential health brands that Johnson & Johnson had built up over a century. Kimberly-Clark agreed to acquire Kenvue in November 2025.
Johnson & Johnson separated its consumer health business as Kenvue, which listed in May 2023 and was fully split off through an exchange offer completed on 23 August 2023. Tylenol, Band-Aid, Listerine, Neutrogena and Johnson's Baby all moved to the new company.
No tagged news items yet. Headlines are added nightly from public feeds; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
Frequently asked questions
What brands does Kenvue own?
⌄
Kenvue owns 13 consumer brands tracked here, including Listerine, Johnson's Baby, Neutrogena, Band-Aid, Aveeno and Benadryl.
Is Kenvue an American company?
⌄
Yes. Kenvue is headquartered in Summit, New Jersey, United States and was founded in 2023.
Who owns Kenvue?
⌄
Kenvue is a publicly listed company owned by its shareholders; it trades as KVUE on the NYSE.
What was Kenvue's most recent acquisition?
⌄
The most recent completed acquisition recorded here is Tylenol, Band-Aid, Listerine, Neutrogena, Aveeno, Johnson's Baby, Nicorette, Zyrtec, Motrin, Benadryl, OGX, Carefree and Stayfree on 23 August 2023.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.